Nugpo, Herman E.

HRN: 23-23-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2023
CEFTRIAXONE 1G (VIAL)
06/29/2023
07/06/2023
IV
2gms
Q24H
UTI + CAP
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes